Immunome, Inc.
IMNM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$292,963 | -$106,806 | -$36,896 | -$24,711 |
| Dep. & Amort. | $2,102 | $728 | $631 | $755 |
| Deferred Tax | $0 | $0 | -$7,271 | -$500 |
| Stock-Based Comp. | $15,748 | $6,223 | $5,332 | $3,448 |
| Change in WC | $14,874 | $11,997 | $2,243 | $2,778 |
| Other Non-Cash | $149,445 | $80,290 | $7,271 | $4 |
| Operating Cash Flow | -$110,794 | -$7,568 | -$28,690 | -$18,226 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7,173 | -$831 | -$248 | -$79 |
| Net Acquisitions | $0 | $9,276 | $0 | $0 |
| Inv. Purchases | -$186,555 | -$38,929 | $0 | $0 |
| Inv. Sales/Matur. | $155,000 | $0 | $0 | $0 |
| Other Inv. Act. | -$46,335 | $0 | $0 | $0 |
| Investing Cash Flow | -$85,063 | -$30,484 | -$248 | -$79 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$113 |
| Stock Issued | $250,002 | $34 | $32 | $27,225 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$9,473 | $116,374 | $0 | $656 |
| Financing Cash Flow | $240,529 | $116,408 | $32 | $27,768 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $44,672 | $78,356 | -$28,906 | $9,463 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $98,779 | $20,423 | $49,329 | $39,866 |
| End Cash | $143,451 | $98,779 | $20,423 | $49,329 |
| Free Cash Flow | -$164,302 | -$8,399 | -$28,938 | -$18,305 |